DCR-COMP1

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDCR-COMP1
Drug Alias NameDCR-COMP1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionComplement C3 inhibitors
TargetsComplement C3
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlexion Pharmaceuticals IncDicerna Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesDicerna Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A